7th Principal Investigators Meeting Agenda
7th Principal Investigators Meeting
Innovative Molecular Analysis Technologies Program
September 7-8, 2006
Bethesda Marriot Hotel (Pooks Hill)
Bethesda, Maryland
Agenda
| THURSDAY, SEPTEMBER 7, 2006 | |
| 7:30 a.m. - 8:30 a.m. | Registration and Continental Breakfast |
| 7:30 a.m. - 8:30 a.m. | Poster Setup |
| 8:30 a.m. - 8:50 a.m. |
Welcoming Remarks Gregory J. Downing, D.O., Ph.D. National Cancer Institute |
| 8:50 a.m. - 9:50 a.m. |
Keynote Presentation Systems Approaches to Predictive Marker Development Joe W. Gray, Ph.D. Lawrence Berkeley National Laboratory |
| 9:50 a.m. - 10:00 a.m. | Break |
| 10:00 a.m. - 12:20 p.m. |
Session 1: Sample Preparation Moderator: Rebecca L. Huppi, Ph.D. National Cancer Institute Determining Agreement in Molecular Data Across Different Methods of Tissue Procurement Philip S. Bernard, M.D. Huntsman Cancer Institute Recovery of Protein From Formalin-Fixed Paraffin- Embedded Tissue Timothy O’Leary, M.D., Ph.D. Veterans Health Administration A Chip-Based RNA Sensor Platform for Detection of Circulating Tumor Cells Gary A. Clawson, M.D., Ph.D. Pennsylvania State University Microfluidic Platform for Live Cell Screening Philip Lee, Ph.D. CellASIC Corporation |
| 12:20 p.m. - 1:20 p.m. | Lunch |
| 1:20 p.m. - 2:05 p.m. |
Electronic Submissions and Alternative Funding Opportunities
SF424/Electronic Transition Requirements Scarlett Gibb National Institutes of Health Alternative Funding Opportunities Jennifer Couch, Ph.D. National Cancer Institute |
| 2:05 p.m. - 2:15 p.m. | Break |
| 2:15 p.m. - 4:15 p.m. |
Session 2: Proteomics Moderator: Paul Wagner, Ph.D. National Cancer Institute Mapping Endothelium and Its Caveolae In Vivo to Improve Antibody Pentetration, Imaging, and Therapy of Solid Tumors Jan E. Schnitzer, M.D. Sidney Kimmel Cancer Center Diverse Novel Approaches for Proteomics of Posttranslational Modifications Yingming Zhao, Ph.D. University of Texas Southwestern Medical Center Selective Profiling of Proteins in Cancer Cells From Fine-Needle Aspirates by MALDI-TOF Mass Spectrometry Michelle L. Reyzer, Ph.D. Vanderbilt University Detection and Identification of Cysteine Sulfenic Acids in Proteins Involved in Signal Transduction Pathways Leslie B. Poole, Ph.D. Wake Forest University School of Medicine Nanoparticles for Efficient Delivery to Solid Tumors Suzie Pun, Ph.D. University of Washington |
| 4:15 p.m. - 5:45 p.m. | Poster Session |
| FRIDAY, SEPTEMBER 8, 2006 | |
| 8:00 a.m. - 9:00 a.m. | Registration and Continental Breakfast |
| 9:00 a.m. - 11:30 a.m. |
Session 3: Cellular Imaging Moderator: Jennifer Couch, Ph.D. National Cancer Institute Identifying the Cancer Stem Cell: Lessons Learned From Hematopoiesis and Acute Leukemia Scott W. Hiebert, Ph.D. Vanderbilt University Automated Cell Preparation in Tubes for 3D Microscopy Mark R. Holl, Ph.D. University of Washington Imaging Transcriptional Activation in Gliomas E. Antonio Chiocca, M.D., Ph.D. James Cancer Hospital and Solove Research Institute Sensing and Imaging Activated Fibroblast in Tumor Stroma Ching Tung, Ph.D. Massachusetts General Hospital/Harvard Medical School Age-Dependent Accumulation of Recombinant Cells in the Mouse Pancreas Revealed In Situ by Fluorescence Imaging Bevin Engleward, Ph.D. Massachusetts Institute of Technology |
| 11:30 a.m. - 12:30 p.m. | Lunch |
| 12:30 p.m. - 2:30 p.m. |
Session 4: Molecular Biology Moderator: J. Randy Knowlton, Ph.D. National Cancer Institute Development of High-Throughput Methods for the in vitro Selection of RNA Aptamers That Can Distinguish Between Tumor Cell Types Andrew D. Ellington, Ph.D. University of Texas at Austin Facile Characterization of Protein Structure/Function With Enhanced Peptide Amide Hydrogen/Deuterium Exchange Mass Spectrometry (DXMS) Virgil L. Woods, Jr., M.D. University of California, San Diego Analysis of Genetic and Epigenetic Alterations in DNA Archives Generated From Tumors of the Head and Neck Paul M. Lizardi, Ph.D. Yale University School of Medicine Prostate Cancer Gene Discovery Using Transposon-Based Somatic Mutagenesis Lara S. Collier, Ph.D. University of Minnesota Cancer Center Solid-Phase Assays of Oncogenic Tyrosine Kinase Activity for Use in Diagnostics and Drug Discovery Stephen J. Kron, M.D., Ph.D. University of Chicago |
| 2:30 p.m. - 3:00 p.m. | Closing Remarks |
| 3:00 p.m. | Adjournment and Poster Removal |
Back to Top
